What is the Medplus Health Services Ltd share price today?

The share price of NSE:MEDPLUS-EQ on 01 Oct 2026 (as of 15:04:15 IST) is ₹653.6.

What is the NSE:MEDPLUS-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:MEDPLUS-EQ 52 week high low range shows a high of ₹1022.2 and a low of ₹642.6.

What is the Medplus Health Services Ltd market cap?

As on 01 Oct 2026, Medplus Health Services Ltd market cap is ₹78647700000.

What is the shareholding pattern of Medplus Health Services Ltd Stock?

The shareholding pattern of Medplus Health Services Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 40.19% Foreign Institutional Investors (FII): 14.38% Domestic Institutional Investors (DII): 5.44% Mutual Funds: 24.51% Retail & Others: 15.48% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Medplus Health Services Ltd?

The Price-to-Earnings (PE) ratio of Medplus Health Services Ltd is 37.3682, and the Price-to-Book (PB) ratio is 5.1123, as on 01 Oct 2026.

Medplus Health Services Share Price

599.10+3.85 (+0.65%)

-26.94% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+0.65%

1 Week

+3.31%

1 Month

-7.03%

3 Month

-13.20%

6 Month

-31.51%

YTD

-25.79%

1 Year

-26.94%

5 Year

10 Year

Max

-42.39%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

589.90

588.50

565.60

High

601.90

610.00

655.55

704.95

1022.20

About

Medplus Health Services Limited is one of India's leading healthcare companies with an ever-growing number of pharmacy stores, online pharmacy, path labs and optical services. It offers a wide range Read more

Retailing

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

DMARTNSE

TRENTNSE

VMMNSE

METROBRANDNSE

ABLBLNSE

PNGJLNSE

MEDPLUSNSE

ETHOSLTDNSE

AVLNSE

V2RETAILNSE

LTP

1W Low

1W High

Market cap (₹)

3373.2+174.2 (5.45%)

3185.70

3408

2,18,850Cr

3037.6+20.3 (0.67%)

2990

3063.30

1,61,682Cr

90.58+6.18 (7.32%)

84.16

91.41

42,257Cr

852.8+29.55 (3.59%)

817.25

861.25

22,692Cr

72.99+2.48 (3.52%)

71.46

74.98

8,927Cr

582.8+24.25 (4.34%)

548.10

583.75

8,475Cr

599.1+19.2 (3.31%)

588.50

610

7,170Cr

2735.8+234.1 (9.36%)

2495.60

2746.70

7,071Cr

523.35-25.7 (-4.68%)

521.25

548.30

6,821Cr

159.63+12.16 (8.25%)

148

167.42

6,009Cr

Medplus Health Services Share Price

599.10+3.85 (+0.65%)

-26.94% past 1 Year

Financial overview

Compounded Sales Growth

10 years15%

5 years18%

3 years15%

Last year12%

Compounded Profit Growth

10 years38%

5 years28%

3 years64%

Last year46%

Stock Price CAGR

10 years-

5 years-

3 years-9%

1 year-27%

Return on Equity

10 years10%

5 years8%

3 years9%

Last year12%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
15%	18%	15%	12%
38%	28%	64%	46%
-	-	-9%	-27%
10%	8%	9%	12%

Peer Comparison

Symbol

DMART

TRENT

VMM

METROBRAND

ABLBL

PNGJL

MEDPLUS

ETHOSLTD

AVL

V2RETAIL

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
3,373.2	₹218850 Cr	70.22	11.4	65.52	₹2970 Cr
3,037.6	₹161682 Cr	85.28	8.7	65.06	₹1720 Cr
90.58	₹42257 Cr	47.08	0.34	3.46	₹839 Cr
852.8	₹22692 Cr	54.74	2.78	27.55	₹411 Cr
72.99	₹8927 Cr	43.42	0.43	8.58	₹171 Cr
582.8	₹8475 Cr	17.38	8.23	37.88	₹410 Cr
599.1	₹7170 Cr	33.97	4.67	43.4	₹220 Cr
2,735.8	₹7071 Cr	68.07	10.51	74.9	₹95 Cr
523.35	₹6821 Cr	47.28	1.38	14.76	₹117 Cr
159.63	₹6009 Cr	33.64	1.15	10.77	₹162 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020
₹2037 Cr	₹1880 Cr	₹1864 Cr	₹1806 Cr	₹1679 Cr	₹1543 Cr	₹1510 Cr	₹1561 Cr	₹1576 Cr	₹1489 Cr	₹1491 Cr	₹1441 Cr	₹1409 Cr	₹1284 Cr	₹1253 Cr	₹1190 Cr	₹1121 Cr	₹994 Cr	₹966 Cr	₹933 Cr	₹925 Cr	₹955 Cr	₹806 Cr	₹801 Cr
₹21 Cr	₹20 Cr	₹21 Cr	₹18 Cr	₹17 Cr	₹15 Cr	₹16 Cr	₹13 Cr	₹12 Cr	₹9 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹9 Cr	₹14 Cr	₹11 Cr	₹11 Cr	₹10 Cr	₹13 Cr	₹7 Cr	₹7 Cr	₹4 Cr	₹4 Cr	₹9 Cr
₹2058 Cr	₹1899 Cr	₹1885 Cr	₹1824 Cr	₹1697 Cr	₹1558 Cr	₹1525 Cr	₹1574 Cr	₹1588 Cr	₹1498 Cr	₹1501 Cr	₹1451 Cr	₹1419 Cr	₹1294 Cr	₹1267 Cr	₹1202 Cr	₹1132 Cr	₹1004 Cr	₹979 Cr	₹941 Cr	₹932 Cr	₹959 Cr	₹810 Cr	₹810 Cr
₹1951 Cr	₹1824 Cr	₹1771 Cr	₹1720 Cr	₹1599 Cr	₹1478 Cr	₹1437 Cr	₹1491 Cr	₹1515 Cr	₹1455 Cr	₹1444 Cr	₹1407 Cr	₹1379 Cr	₹1265 Cr	₹1227 Cr	₹1164 Cr	₹1103 Cr	₹979 Cr	₹948 Cr	₹903 Cr	₹890 Cr	₹886 Cr	₹770 Cr	₹765 Cr
₹191 Cr	₹153 Cr	₹190 Cr	₹177 Cr	₹166 Cr	₹146 Cr	₹152 Cr	₹145 Cr	₹136 Cr	₹102 Cr	₹116 Cr	₹102 Cr	₹95 Cr	₹81 Cr	₹95 Cr	₹83 Cr	₹71 Cr	₹63 Cr	₹65 Cr	₹69 Cr	₹69 Cr	₹101 Cr	₹65 Cr	₹67 Cr
₹37 Cr	₹33 Cr	₹33 Cr	₹31 Cr	₹29 Cr	₹27 Cr	₹27 Cr	₹26 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹24 Cr	₹24 Cr	₹23 Cr	₹22 Cr	₹21 Cr	₹20 Cr	₹20 Cr	₹19 Cr	₹17 Cr	₹16 Cr	₹15 Cr	₹15 Cr	₹13 Cr
₹70 Cr	₹42 Cr	₹80 Cr	₹73 Cr	₹69 Cr	₹53 Cr	₹61 Cr	₹57 Cr	₹48 Cr	₹18 Cr	₹32 Cr	₹20 Cr	₹16 Cr	₹5 Cr	₹17 Cr	₹16 Cr	₹9 Cr	₹5 Cr	₹13 Cr	₹22 Cr	₹25 Cr	₹58 Cr	₹26 Cr	₹32 Cr
₹56 Cr	₹33 Cr	₹64 Cr	₹58 Cr	₹56 Cr	₹42 Cr	₹51 Cr	₹46 Cr	₹39 Cr	₹14 Cr	₹34 Cr	₹14 Cr	₹15 Cr	₹4 Cr	₹27 Cr	₹13 Cr	₹6 Cr	₹4 Cr	₹11 Cr	₹17 Cr	₹20 Cr	₹46 Cr	₹18 Cr	₹23 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
—	—	—	—	—	—	—	—	—	—	—	—
₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹45 L	₹19 L	₹19 L	₹19 L	₹12 Cr	₹12 Cr	₹12 Cr
₹8 Cr	₹26 Cr	₹30 Cr	₹30 Cr	₹11 Cr	₹49 Cr	₹9 Cr	₹9 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr
₹1943 Cr	₹1690 Cr	₹1524 Cr	₹1437 Cr	₹1383 Cr	₹681 Cr	₹519 Cr	₹316 Cr	₹297 Cr	₹142 Cr	₹131 Cr	₹135 Cr
₹1943 Cr	₹1690 Cr	₹1524 Cr	₹1437 Cr	₹1383 Cr	₹681 Cr	₹519 Cr	₹316 Cr	₹297 Cr	₹142 Cr	₹131 Cr	₹135 Cr
₹1975 Cr	₹1741 Cr	₹1578 Cr	₹1491 Cr	₹1418 Cr	₹731 Cr	₹528 Cr	₹325 Cr	₹303 Cr	₹160 Cr	₹149 Cr	₹154 Cr
-₹71 L	-₹66 L	-₹57 L	-₹68 L	-₹52 L	₹55 L	₹1 Cr	₹2 L	₹2 L	₹2 L	₹2 L	₹1 L
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹8 Cr	₹54 Cr	₹65 Cr	₹62 Cr
-₹121 Cr	-₹100 Cr	-₹85 Cr	-₹66 Cr	-₹45 Cr	-₹39 Cr	-₹40 Cr	-₹32 Cr	-₹35 Cr	-₹11 Cr	-₹8 Cr	-₹8 Cr
₹1235 Cr	₹1008 Cr	₹869 Cr	₹802 Cr	₹597 Cr	₹401 Cr	₹321 Cr	₹3 Cr	₹3 Cr	₹40 Cr	₹21 Cr	₹7 Cr
₹111 Cr	₹83 Cr	₹65 Cr	₹61 Cr	₹95 Cr	₹37 Cr	₹46 Cr	₹39 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹6 Cr
₹1225 Cr	₹992 Cr	₹849 Cr	₹797 Cr	₹647 Cr	₹399 Cr	₹327 Cr	₹10 Cr	-₹19 Cr	₹88 Cr	₹82 Cr	₹66 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹307 Cr	₹299 Cr	₹253 Cr	₹260 Cr	₹246 Cr	₹148 Cr	₹234 Cr	₹163 Cr	₹129 Cr	₹111 Cr	₹110 Cr	₹103 Cr
₹330 Cr	₹241 Cr	₹242 Cr	₹189 Cr	₹148 Cr	₹111 Cr	₹122 Cr	₹61 Cr	₹35 Cr	₹14 Cr	₹12 Cr	₹4 Cr
₹0	₹0	₹0	₹0	₹143 Cr	₹135 Cr	₹105 Cr	₹104 Cr	₹154 Cr	₹138 Cr	₹139 Cr	₹97 Cr
₹127 Cr	₹84 Cr	₹80 Cr	₹27 Cr	₹22 Cr	₹50 Cr	₹37 Cr	₹9 Cr	₹8 Cr	₹14 Cr	₹8 Cr	₹7 Cr
₹764 Cr	₹625 Cr	₹575 Cr	₹477 Cr	₹559 Cr	₹445 Cr	₹498 Cr	₹337 Cr	₹325 Cr	₹276 Cr	₹269 Cr	₹210 Cr
₹3964 Cr	₹3356 Cr	₹3002 Cr	₹2764 Cr	₹2624 Cr	₹1575 Cr	₹1354 Cr	₹672 Cr	₹610 Cr	₹525 Cr	₹501 Cr	₹430 Cr
₹14 Cr	₹14 Cr	₹14 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹48 Cr	₹0	₹0	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹143 Cr	₹135 Cr	₹105 Cr	₹104 Cr	₹162 Cr	₹192 Cr	₹210 Cr	₹158 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹2558 Cr	₹2051 Cr	₹1862 Cr	₹1616 Cr	₹1114 Cr	₹741 Cr	₹690 Cr	₹160 Cr	₹143 Cr	₹135 Cr	₹122 Cr	₹107 Cr
₹964 Cr	₹755 Cr	₹620 Cr	₹478 Cr	₹315 Cr	₹224 Cr	₹270 Cr	₹71 Cr	₹60 Cr	₹55 Cr	₹46 Cr	₹39 Cr
₹1595 Cr	₹1296 Cr	₹1242 Cr	₹1138 Cr	₹799 Cr	₹517 Cr	₹419 Cr	₹90 Cr	₹83 Cr	₹81 Cr	₹77 Cr	₹67 Cr
₹32 Cr	₹13 Cr	₹5 Cr	₹24 Cr	₹20 Cr	₹6 Cr	₹3 Cr	₹1 Cr	₹89 L	₹2 Cr	₹3 Cr	₹3 Cr
₹191 Cr	₹149 Cr	₹126 Cr	₹120 Cr	₹173 Cr	₹100 Cr	₹97 Cr	₹91 Cr	₹57 Cr	₹47 Cr	₹44 Cr	₹43 Cr
₹2 Cr	₹3 Cr	₹6 Cr	₹15 L	₹2 L	₹5 L	₹4 L	₹15 Cr	₹11 Cr	₹4 L	₹4 L	₹4 L
₹1820 Cr	₹1465 Cr	₹1385 Cr	₹1284 Cr	₹992 Cr	₹622 Cr	₹521 Cr	₹197 Cr	₹152 Cr	₹130 Cr	₹125 Cr	₹113 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹3 L	₹3 L	₹3 L	₹25 L	₹0	₹0	₹5 L	₹4 L	₹5 L
₹1382 Cr	₹1345 Cr	₹1340 Cr	₹1144 Cr	₹915 Cr	₹750 Cr	₹644 Cr	₹394 Cr	₹363 Cr	₹335 Cr	₹310 Cr	₹253 Cr
₹27 Cr	₹13 Cr	₹18 Cr	₹9 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹9 Cr	₹10 Cr	₹2 Cr	₹3 Cr	₹4 Cr
₹462 Cr	₹367 Cr	₹142 Cr	₹284 Cr	₹34 Cr	₹119 Cr	₹141 Cr	₹50 Cr	₹58 Cr	₹41 Cr	₹50 Cr	₹48 Cr
₹16 Cr	₹15 Cr	₹11 Cr	₹10 Cr	₹32 Cr	₹8 Cr	₹13 Cr	₹10 Cr	₹7 Cr	₹69 L	₹53 L	₹58 L
₹256 Cr	₹151 Cr	₹106 Cr	₹34 Cr	₹645 Cr	₹71 Cr	₹29 Cr	₹12 Cr	₹18 Cr	₹16 Cr	₹12 Cr	₹11 Cr
₹2143 Cr	₹1891 Cr	₹1616 Cr	₹1481 Cr	₹1632 Cr	₹953 Cr	₹833 Cr	₹475 Cr	₹458 Cr	₹395 Cr	₹376 Cr	₹317 Cr
₹1379 Cr	₹1267 Cr	₹1042 Cr	₹1004 Cr	₹1073 Cr	₹508 Cr	₹335 Cr	₹138 Cr	₹132 Cr	₹118 Cr	₹107 Cr	₹107 Cr
₹3964 Cr	₹3356 Cr	₹3002 Cr	₹2764 Cr	₹2624 Cr	₹1575 Cr	₹1354 Cr	₹672 Cr	₹610 Cr	₹525 Cr	₹501 Cr	₹430 Cr
₹164	₹143	₹129	₹122	₹118	₹15,221	₹26,758	₹16,318	₹15,335	₹8,461	₹7,816	₹8,057
₹164	₹143	₹129	₹122	₹118	₹3,044	₹2,379	₹1,450	₹1,363	₹752	₹695	₹716

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
₹275 Cr	₹183 Cr	₹73 Cr	₹47 Cr	₹118 Cr	₹95 Cr	₹29 Cr	₹37 Cr	₹26 Cr	₹48 Cr	₹19 Cr	₹14 Cr
₹394 Cr	₹354 Cr	₹331 Cr	₹273 Cr	₹188 Cr	₹182 Cr	₹155 Cr	₹35 Cr	₹43 Cr	₹10 Cr	₹8 Cr	₹7 Cr
-₹99 Cr	₹49 Cr	-₹231 Cr	-₹216 Cr	-₹102 Cr	-₹246 Cr	-₹176 Cr	₹23 Cr	-₹13 Cr	-₹26 Cr	-₹48 Cr	-₹46 Cr
₹570 Cr	₹586 Cr	₹173 Cr	₹104 Cr	₹203 Cr	₹32 Cr	₹8 Cr	₹95 Cr	₹56 Cr	₹32 Cr	-₹21 Cr	-₹25 Cr
₹496 Cr	₹540 Cr	₹144 Cr	₹90 Cr	₹170 Cr	₹3 Cr	-₹7 Cr	₹82 Cr	₹32 Cr	₹34 Cr	-₹17 Cr	-₹19 Cr
-₹128 Cr	-₹318 Cr	-₹83 Cr	₹429 Cr	-₹703 Cr	-₹35 Cr	-₹28 Cr	-₹20 Cr	-₹18 Cr	-₹15 Cr	-₹32 Cr	-₹15 Cr
-₹256 Cr	-₹228 Cr	-₹198 Cr	-₹170 Cr	₹440 Cr	-₹6 Cr	₹90 Cr	-₹72 Cr	-₹88 L	-₹29 Cr	₹35 Cr	₹66 Cr
₹112 Cr	-₹5 Cr	-₹137 Cr	₹350 Cr	-₹93 Cr	-₹37 Cr	₹56 Cr	-₹10 Cr	₹14 Cr	-₹10 Cr	-₹15 Cr	₹32 Cr
₹86 Cr	₹91 Cr	₹228 Cr	-₹121 Cr	-₹28 Cr	₹9 Cr	-₹47 Cr	₹35 Cr	₹21 Cr	₹31 Cr	₹46 Cr	₹13 Cr
₹198 Cr	₹86 Cr	₹91 Cr	₹228 Cr	-₹121 Cr	-₹28 Cr	₹9 Cr	₹24 Cr	₹35 Cr	₹21 Cr	₹31 Cr	₹45 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Medplus Health Services Share Price

599.10+3.85 (+0.65%)

-26.94% past 1 Year

Shareholding summary

Promoters

40.19%

FII

12.58%

DII

4.5%

27.39%

Others

15.34%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
40.19%	40.19%	40.22%	40.29%	40.29%	40.32%
12.58%	14.38%	15.53%	16.83%	16.53%	16.43%
4.50%	5.44%	5.22%	5.10%	5.03%	4.56%
27.39%	24.51%	22.60%	21.48%	21.48%	21.47%
15.34%	15.48%	16.43%	16.30%	16.67%	17.22%

Bulk & block deals

Name

Graviton Research Capital Llp

Franklin Templeton Mf India Smaller Companies Fund

Sbi Mutual Fund

Kotak Small Cap Fund

Morgan Stanley Asia Singapore Pte

Pi Opportunities Fund - I

Invesco Mutual Fund

Invesco Trustee Pvt Ltd A/C Invesco India Midcap Fund

Kotak Mahindra Mutual Fund

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
03 Nov 2025	Purchase	56.38 Cr	₹836.74	6.74 L	Bulk	0.562352	NSE
03 Nov 2025	Sell	56.40 Cr	₹837.39	6.73 L	Bulk	0.562078	NSE
18 Nov 2024	Purchase	54.46 Cr	₹700	7.78 L	Bulk	0.647552	NSE
18 Nov 2024	Sell	70 Cr	₹700	10 L	Bulk	0.832382	NSE
18 Nov 2024	Purchase	174.69 Cr	₹700	24.96 L	Bulk	2.07724	NSE
18 Nov 2024	Purchase	10 Cr	₹700	1.43 L	Block	0.118912	NSE
18 Nov 2024	Sell	482.55 Cr	₹700	68.94 L	Bulk	5.738097	NSE
18 Nov 2024	Purchase	215 Cr	₹700	30.71 L	Block	2.556603	NSE
18 Nov 2024	Purchase	68.89 Cr	₹700	9.84 L	Bulk	0.819162	NSE
18 Nov 2024	Purchase	215 Cr	₹700	30.71 L	Block	2.556603	NSE

Insider trading & SAST

Client name

Lone Furrow Investment Private Ltd

Agilemed Investment Pvt Ltd

Alka Ajit Rangnekar

Agilemed Investment Pvt Ltd

Lone Furrow Investment Private Ltd

Agilemed Investment Pvt Ltd

Icici Prudential Mutual Fund

Agilement Investment Pvt Ltd

Agilemed Investments Private Limited

Agilemed Investment Pvt Ltd1

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
12 Oct 2026	Promoter	Pledge	—	—	0	—	16 L	29 Sep 2026	Creation	70,00,000	SAST	Reg31	—
08 Oct 2026	Promoter	Pledge	—	—	0	—	5.50 L	30 Sep 2026	Creation	1,34,27,525	SAST	Reg31	—
01 Sep 2026	Directors Immediate Relative	Acquisition	0.003101	0	24.45 L	₹656.50	3.73 K	17 Aug 2026	Off Market	3,725	Insider Trading	—	Equity
28 Aug 2026	Promoter	Pledge	—	—	0	—	5 L	19 Aug 2026	Creation	1,28,77,525	SAST	Reg31	—
07 Aug 2026	Promoter	Pledge	—	—	0	—	29 L	24 Jul 2026	Creation	54,00,000	SAST	Reg31	—
07 Aug 2026	Promoter	Pledge	—	—	0	—	9 L	24 Jul 2026	Creation	1,23,77,525	SAST	Reg31	—
05 Aug 2026	Other	Acquisition	0.14	5.07	0	—	1.76 L	22 Jul 2026	Market	60,94,338	SAST	29(1)	—
02 Jan 2026	Promoter	Pledge	—	—	0	—	41.72 L	24 Dec 2025	Release	1,14,77,525	SAST	Reg31	—
26 Dec 2025	Promoter	Revoke	3.481789	13.06	339.85 Cr	₹814.60	41.72 L	24 Dec 2025	Revocation Of Pledge	1,56,49,495	Insider Trading	—	Equity Shares
23 Dec 2025	Promoter	Pledge	—	—	0	—	48.51 L	16 Dec 2025	Creation	1,56,49,495	SAST	Reg31	—

Medplus Health Services Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Medplus Health Services Share Price

Medplus Health Services Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Medplus Health Services Share Price

Medplus Health Services Share Price

Oscillators

Moving averages

Medplus Health Services Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Medplus Health Services Share Price

Corporate Actions

Company details

Medplus Health Services Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Medplus Health Services Share Price

News

MedPlus Q2 EBITDA Rises Despite Year On Year Margin Contraction

MedPlus Q2 Consolidated Profit Rises Marginally Revenue Grows Strongly

MedPlus Q2 Revenue Rises 21.3 Percent Year on Year to Rs 2,037 Crores

Medplus Health Services to acquire remaining stake in Optival Health Solutions

Medplus sees sizeable Rs 60.69 crore BSE block trade at Rs 698

Medplus Health okays Rs 115 crores Hyderabad health, wellness capex plan

MedPlus Health Services approves Rs 40 crores capex for Hyderabad food park

Medplus Health Q1 FY27 EBITDA edges up, margin compresses year-on-year

Medplus Health Services posts strong YoY revenue growth in latest Q1 results

Medplus Health Services Q1 net profit falls to Rs 33.20 crore

Medplus Health Services to host Q1 earnings conference call on July 22

Medplus subsidiary sees Karnataka store drug licence temporarily suspended

Medplus subsidiary faces multiple short-term drug license suspensions in India

Medplus announces suspension of drug license for Karnataka store

Medplus Health Servi reports Profit after tax of 16.67 Crores, in the March 2026 quarter

Medplus Health Q4 EBITDA rises year-on-year with stable operating margin profile

Medplus Health Q4 profit and revenue rise strongly on robust sales growth

Medplus Health Services Subsidiary Optival Health Solutions Receives Suspension Orders for Two Drug Store Licenses

Medplus Health Services informs about updates

Medplus Health Services Subsidiary Faces Seven-Day Drug License Suspension in Maharashtra, Revenue Loss Rs 3.85 Lakhs.

Medplus Health Services Ltd Share Price Today

Medplus Health Services Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator